AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine, as well as develops ABP-450 for the treatment of gastroparesis and post-traumatic stress disorder. The company has license agreements Daewoong Pharmaceu...
Oct 1, 2025, 8:00 AM EDT - 24 days ago
Aug 12, 2025, 4:05 PM EDT - 2 months ago
May 23, 2025, 4:05 PM EDT - 5 months ago
May 19, 2025, 4:05 PM EDT - 5 months ago
May 14, 2025, 4:05 PM EDT - 5 months ago
Apr 25, 2025, 4:05 PM EDT - 6 months ago
Apr 21, 2025, 4:05 PM EDT - 6 months ago
Mar 27, 2025, 4:05 PM EDT - 7 months ago
Mar 24, 2025, 4:05 PM EDT - 7 months ago
Mar 4, 2025, 8:00 AM EST - 8 months ago
Feb 24, 2025, 2:00 PM EST - 8 months ago
Feb 7, 2025, 4:05 PM EST - 9 months ago
Jan 7, 2025, 9:37 AM EST - 10 months ago
Jan 3, 2025, 8:02 PM EST - 10 months ago
Nov 13, 2024, 4:05 PM EST - 1 year ago
Aug 19, 2024, 4:05 PM EDT - 1 year ago
Aug 12, 2024, 4:05 PM EDT - 1 year ago
May 29, 2024, 8:00 AM EDT - 1 year ago
May 14, 2024, 4:05 PM EDT - 1 year ago
May 9, 2024, 8:00 AM EDT - 1 year ago
May 3, 2024, 7:00 AM EDT - 1 year ago
Mar 30, 2024, 10:53 PM EDT - 1 year ago
Mar 29, 2024, 4:15 PM EDT - 1 year ago
Mar 29, 2024, 3:45 PM EDT - 1 year ago
Mar 19, 2024, 4:30 PM EDT - 1 year ago
Mar 19, 2024, 4:29 PM EDT - 1 year ago
Jan 18, 2024, 4:05 PM EST - 1 year ago
Dec 12, 2023, 8:00 AM EST - 2 years ago
Nov 13, 2023, 8:15 AM EST - 2 years ago
Oct 19, 2023, 4:05 PM EDT - 2 years ago
Aug 29, 2023, 8:00 AM EDT - 2 years ago
Aug 24, 2023, 8:00 AM EDT - 2 years ago
Aug 16, 2023, 7:00 AM EDT - 2 years ago
Jul 24, 2023, 7:00 AM EDT - 2 years ago